Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 232-241

  Liu, Zhendong ^a   Lu, Fanghong ^a   Pan, Hui ^a   Zhao, Yingxin ^a   Wang, Shujian ^a   Sun, Shangwen ^a   Li, Jun ^a   Hu, Xiaoliang ^a   Wang, Lin ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atherosclerotic plaque; Th17 cell; Th17 associated cytokines

Indexed keywords

GLUCOSE; INTERLEUKIN 17; INTERLEUKIN 6; LIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CAROTID ARTERIOGRAPHY; CAROTID ATHEROSCLEROSIS; CELL LEVEL; CONTROLLED STUDY; CROUSE SCORE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEX DIFFERENCE; TH17 CELL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; CHINA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; LINEAR MODELS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862810919     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.026     Document Type: Article

References (31)

1. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
2. Weber C., Zermecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8:802-815.
3. Hansson G.K., Libby P., Schonbeck U., Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2009, 91:281-291.
4. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
5. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011, 12:204-212.
6. Paulsson G., Zhou X., Törnquist E., Hansson G.K. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2000, 20:10-17.
7. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453:1051-1057.
8. Wang Z., Lee J., Zhang Y., et al. Increased Th17 cells in coronary artery disease are associated with neutrophilic inflammation. Scand Cardiovasc J 2011, 45:54-61.
9. Taleb S., Tedguu A., Mallat Z. Interleukin-17: friend or foe in atherosclerosis?. Curr Opin Lipidol 2010, 21:404-408.
10. Chen S., Crother T.R., Arditi M. Emerging role of IL-17 in atherosclerosis. J Innate Immun 2010, 2:325-333.
11. Chambless L.E., Folsam A.R., Davis V., et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2002, 155:38-47.
12. Crrinholdt M-L.M. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol 1999, 19:2-13.
13. Sramek A., Bosch J.G., Reiber J.H., Van Oostayen J.A., Rosendaal F.R. Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries. Invest Radiol 2000, 35:699-706.
14. Crouse J.R., Byington R.P., Bond M.G., et al. Pravastatin, lipids and atherosclerosis in carotid arteries (PLAC-II) [J]. Am J Cardiol 1995, 75:455-459.
15. Zhang J., Hua G., Zhang X., Tong R., Du X., Li Z. Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events. Nephrologh (Cariton) 2010, 15:33-41.
16. Cheng X., Yu X., Ding Y.J., et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008, 127:89-97.
17. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6:508-519.
18. Frostegard J., Ulfgren A.-K., Nyberg P., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145:33-43.
19. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-gamma potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 1997, 99:2752-2761.
20. Miossec P., Korm T., Duchroo V.K. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009, 361:888-898.
21. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
22. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007, 8:1390-1397.
23. Luger D., Caspi R.R. New perspectives on effector mechanisms in uveitis. Semin Immunopathol 2008, 30:135-143.
24. Ke Y., Liu K., Huang G.Q., et al. Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J Immunol 2009, 182:3183-3190.
25. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007, 8:345-350.
26. Ivanov I.I., McKenzie B.S., Zhou L., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
27. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
28. Erbel C., Chen L., Bea F., et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in ApoE-deficient mice. J Immunol 2009, 183:8167-8175.
29. -/- mice. Cytokine 2010, 49:185-193.
30. Smith E., Prasad K.M., Butcher M., et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010, 121:1746-1755.
31. Taleb S., Romain M., Ramkhelawon B., et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009, 206:2067-2077.